Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 22

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 22
---
 stock may also be based on other
factors which may be unrelated to the number of shares outstanding, including our future performance. If the Reverse Stock Split is consummated
and the trading price of the common stock declines, the percentage decline as an absolute number and as a percentage of our overall market
capitalization may be greater than would occur in the absence of the Reverse Stock Split. Even if the market price per post-Reverse Stock
Split share of our common stock remains in excess of $1.00 per share, we may be delisted due to a failure to meet other continued listing
requirements, including Nasdaq requirements related to the minimum stockholder equity requirement, the minimum number of shares that must
be in the public float, the minimum market value of the public float and the minimum number of “round lot” holders.

The proposed Reverse Stock Split may decrease the liquidity of our common stock and result in higher transaction costs. The liquidity of our common stock may be negatively impacted
by a Reverse Stock Split, given the reduced number of shares that would be outstanding after the Reverse Stock Split, particularly if
the stock price does not increase as a result of the Reverse Stock Split. In addition, if a Reverse Stock Split is implemented, it will
increase the number of our stockholders who own “odd lots” of fewer than 100 shares of common stock. Brokerage commission
and other costs of transactions in odd lots are generally higher than the costs of transactions of more than 100 shares of common stock.
Accordingly, a Reverse Stock Split may not achieve the desired results of increasing marketability and liquidity of our common stock described
above.

If our stockholders approve this Proposal 1, the effective increase in the authorized number of shares of our common stock as a result ofthe Reverse Stock Split could have anti-takeover implications. If our stockholders approve this Proposal 1, the implementation of a Reverse Stock Split will result
in an effective increase in the authorized number of shares of our common stock available for issuance (as our authorized number of shares
of common stock will remain at 60,000,000 shares), which could, under certain circumstances, have anti-takeover implications. The additional
shares of common stock that would become available for issuance if this Proposal 1 is approved and a Reverse Stock Split is implemented
could be used by us to oppose a hostile takeover attempt or to delay or prevent changes in control or our management. For example, without
further stockholder approval, the Board of